This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of AbbVie Inc. (ABBV) slid 0.76% to $151.87 Wednesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.83% to 3,958.79 and Dow Jones Industrial Average falling 0.12% to 33,553.83. The stock's fall snapped a four-day winning streak. AbbVie Inc. closed $24.04 below its 52-week high ($175.91), which the company reached on April 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Pfizer Inc. (PFE) fell 1.07% to $48.05, Eli Lilly & Co. (LLY) rose 0.85% to $352.93, and AstraZeneca PLC ADR (AZN.LN) fell 0.23% to $63.80. Trading volume (7.2 M) eclipsed its 50-day average volume of 5.7 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 16, 2022.
(END) Dow Jones Newswires
November 16, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.